Drugs - 3

Deadline:26 May 2026, 08:00

Tender information

Скопски

Type

Contract

Procedure

Open procedure

Ref. number

07244/2026

Contract type

Framework agreement

Duration

12 months

Drugs - 3

A02BA03 Famotidine film-coated tablet 40 mg

A02BC02 Pantoprazole solution for injection or infusion 40 mg

A04AA01 Ondansetron solution for injection 8mg/4ml, 4mg/2 ml

A04AA01 Ondansetron Tablets 4mg

A04AA02 Granisetron solution for injection or infusion 1mg/1ml (3mg/3ml)

A05AA02 Ursodeoxycholic acid capsule, hard 250 mg

A07AA02 Nystatin Powder for oral suspension 100000 IU/ml

A07AX03 Nifuroxazide Capsules 200mg

A10AB05 insulin aspart solution for injection 100 E/1 ml (1 ml 100 E 3,5 mg)

B01AB01 Heparin solution for injection 25000 IE/ 5ml

B01AB05 Enoxoparin (originator) injection solution 4000 anti-Xa ie/0,4ml

B01AB05 Enoxoparin (biosimilar) injection solution 4000 anti-Xa ie/0,4ml

B01AB06 Nadroparin injection solution 3800IE anti-Xa ie/0,4ml

B01AB06 Nadroparin injection solution 5700 IE anti-Ха/0,6 ml

B02BA01 Phytomenadione solution for injection 10 mg/ ml

B03XA01 Erythropoetin solution for injection 4000 IE

B03XA01 Erythropoetin solution for injection 2 000 IE

B05AA01 Human albumin (albumin) solution for infusion 20% (50ml)

B05BA03 Glucose Solution for infusion 5%/500 ml

B05BA10 Amino acids, combinations with electrolytes Emulsion for infusion 1026ml

B05BA10 Solution for parenteral nutrition, combinations Emulsion for infusion PE bag х 1440 ml

B05BB01 electrolytes (Na,K,Ca/Cl lactate solution for infusion)

B05BB01 electrolytes (Na,K,Ca/Cl solution for infusion)

B05BC01 Mannitol Solution for infusion 20%/250ml

B05CX10 Sorbitol, Mannitol 2.7%/0.54% (5000ml)

B05XA03 Sodium chloride Solution for infusion 0.9% 100ml

B05XA03 Sodium chloride Solution for infusion 0.9% 1000ml

B05XA03 Sodium chloride Solution for infusion 0.9% 500ml

C01AA05 Digoxin solution for injection or infusion 0.5mg /2ml

C01AA08 Metildigoxin tablet 0,1mg

C01CA04 Dopamine concentrate for solution for infusion 40mg/ml

C01CA24 Epinephrine solution for injection or infusion 1 mg/ 1ml

C03CA01 Furosemide solution for injection or infusion 20mg/2ml

C08CA01 Amlodipine tablet 10 mg

C09AA02 | Enalapril | Tablets | 20mg

G02AB01 | Methylergometrine | Solution for Injection | 0,2 mg/1 ml

G04BD09 | Trospium | Tablet | 5 mg

G04BD09 | Trospium | Solution for Injection | 0.2mg/5ml

H01CB02 | Octreotide | Solution for Injection | 0.1mg/1ml

H02AB02 | Dexamethasone | Solution for Injection | 4mg/1ml

H02AB02 | Dexamethasone | Tablet | 8 mg

H02AB04 | Methylprednisolone, Methylprednisolone succinate natrium 40 mg/ 1 ml (40mg)

H02AB04 | Methylprednisolone, Methylprednisolone succinate natrium 500mg/7,8ml

H02AB06 | Prednisolone | Tablet | 20 mg

H02AB06 | Prednisolone | Tablet | 50 mg

J01CE10 | Benzathine phenoxymethylpenicillin | Film Coated Tablet | 1500000 IE

J01CR02 | Amoxicillin, clavulanic acid | Film-coated tablet/oral suspension tablet | 875 mg/125 mg

J01CR05 | Piperacilin,Tazobactam | Solution Powder for Injection or Infusion | 4g /0,5g

J01DD02 | Ceftazidime | powder for solution for injection or infusion | 1 g

J01DD04 | Ceftriaxone | Solution Powder for Injection 2 g

J01DH02 | Meropenem | powder for solution for injection or infusion | 500 mg

J01DH03 | Ertapenem | Concentrate powder for solution for infusion | 1000 mg

J01DH51 | Imipenem+Cilastatin | Solution Powder for Infusion 500mg/500mg

J01EE01 | sulfamethoxasole + trimetoprim | Tablet | (400+80) mg

J01FA10 | Azithromycin | Film-coated tablet | 500 mg

J01FA10 | Azithromycin | Powder Solution For Infusion | 500 mg

J01FF01 | Clindamycin | Capsules | 300 mg

J01FF01 | Clindamycin | Solution for Injection | 600mg/2ml

01GB03 | Gentamicin | Solution for Injection | 120 mg/2 ml, 120 mg/1.5ml

J01GB06 | Amikacin | solution for injection or infusion | 500 mg/2ml

J01MA02 | Ciprofloxacin | Film-coated tablet | 500 mg

J01MA02 | Ciprofloxacin | Concentrate for solution for infusion | 100mg/10ml

J01XA01 | Vancomycin | powder for solution for infusion or for oral solution | 1000 mg,1g

J01XD01 | Metronidazole | Solution for infusion | 500 mg/100 ml, 5mg/1ml,0.5%

J02AA01 | Amphotericin B | Suspension concentrate for infusion | 50 mg

J02AC01 | Fluconazole | Capsule | 100 mg

J02AC01 | Fluconazole | Solution for infusion | 200mg/100ml

J05AB01 | Aciclovir | Tablet | 200 mg

J05AB01 | Aciclovir | Solution Powder for Injection/Infusion | 250mg

J05AB14 | Valganciclovir | Film-coated tablet | 450 mg

J06BA02 | Immunoglobulins, normal human (i.v.) | Solution for infusion | 5 g/50ml, 5g/100ml

J06BA02 | Immunoglobulins, normal human (i.v.) | Solution for infusion | 10g/100ml,10 g/200ml

J06BB01 | Anti-D (rh) immunoglobulin | Solution for Injection/Powder and Vehiculum | 300 mcg (1500 IE),300 mcg/2ml

L01AA01 | Cyclophosphamide | Coated Tablet | 50mg

L01AA01 | Cyclophosphamide | Solution Powder for Injection | 500mg

L01AA01 | Cyclophosphamide |Solution Powder for Injection | 500mg

L01AA01 | Cyclophosphamide | Solution Powder for Injection | 1000mg

L01AA02 | Chlorambucil | Film Coated Tablet | 2 mg

L01AA03 | Melphalan | Film Coated Tablet | 2 mg

L01AA03 | Melphalan | powder and vehiculum for solution for injection or infusion | 50mg

L01AA06 | Ifosfamide | powder for solution for injection or infusion | 1g

L01AD01 | Carmustine | Powder and vehiculum for solution for infusion | 100mg

L01AX04 | Dacarbazine | powder for solution for infusion or injection | 500 mg

L01BA01 | Methotrexate | solution for injection or infusion | 50mg/5ml

L01BA01 | Methotrexate | Concentrate for solution for infusion | 500 mg/5 ml

L01BB02 | Mercaptopurine | Tablet | 50 mg

L01BB03 | Tioguanine | Tablet | 40 mg

L01BB04 | Cladribine | Solution for Injection | 2mg/1ml (5ml)

L01BB05 | Fludarabine | concentrate for solution for injection or infusion 50 mg/2ml, 25mg/1ml,50mg

L01BC01 | Cytarabine | Solution for Injection | 500 mg

L01BC05 | Gemcitabine | Infusion Solution Powder/Concentrate for Infusion Solution | 2g

L01CA01 | Vinblastine | Solution Concentrate for Infusion/Powder for Solution for Infusion/Injection | 10 mg/10ml

L01CA02 | Vincristine | Lyophilisate for solution for injection or infusion | 1mg

L01CB01 | Etoposide | Concentrate for solution for infusion | 100mg/5ml

L01DB01 | Doxorubicin | solution for injection/ powder for solution for injection or infusion | 50mg

L01DB02 | Daunorubicin | powder and vechiculum for solution for injection | 20 mg/10ml

L01DB06 | Idarubicin | Solution for Injection, Powder for Solution for Injection | 20 mg

L01DC01 | Bleomycin | Solution Powder for Injection | 15 IE

L01XA01 | Cisplatin | Concentrate for solution for infusion | 100 mg

L01XA02 | Carboplatin | Concentrate for solution for infusion | 450mg

L01XB01 | Procarbazine | capsule/tablet | 50 mg

L01XX05 | Hydroxycarbamide | capsule, hard | 500 mg

L01XX14 | Tretinoin | Capsule,soft | 10 mg

L03AA02 | Filgrastim | solution for injection or infusion | 48IU/0.5ml

L03AA13 | Pegfilgrastim | Solution for Injection | 6 mg/0.6 ml

L03AA14 | Lipegfilgrastim | Solution for Injection | 6mg/0.6ml

L04AA03 | Antilimphocyte immunoglobulin | Concentrate for solution for infusion | 250mg/5ml

L04AA03 | Antilymphocyte immunoglobulin | Concentrate for solution for infusion | 250mg/5ml

L04AA04 | Antithymocyte immunoglobulin (rabbit) | Concentrate for solution for infusion | 20MG/5ML

L04AA06 | Mycophenolic acid | capsule/capsule, hard | 500 mg

L04AD01 | Ciclosporin | Capsule | 50 mg

L04AD01 | Ciclosporin | Capsule | 25 mg

L04AD01 | Ciclosporin | Capsule | 100 mg

L04AD01 | Ciclosporin | Infusion Solution Concentrate | 50mg/1ml

L04AX01 | Azathioprine | Film Coated Tablet | 50mg

L04AX02 | Thalidomide | Tablet | 100 mg

M01AE03 | Ketoprofen | Film Coated Tablet | 100 mg

M01AE03 | Ketoprofen | Solution for Injection | 100mg/2ml

M04AA01 | Allopurinоl | Tablet | 100 mg

N01BB02 | lidocaine | Solution for Injection | 20mg/ml (5ml)

N02AX02 | Tramadol | Solution for Injection | 100 mg

N02BB02 | Metamizole sodium | Solution for Injection | 2,5g/5ml

N02BE01 | Paracetamol | Tablet | 500mg

N02BE01 | Paracetamol | Infusion Solution/Infusion Solution Concentrate | 1 g

N03AF01 | Carbamazepine | Tablet | 200mg

N05AA03 | Promazine | Solution for Injection | 100mg/2ml

N05BA01 | Diazepam | tablet,coated tablet | 5 mg

N05BA01 | Diazepam | solution for injection or infusion | 5mg/ml

R03DA05 | Aminophylline | Solution for Injection | 250mg/10ml

R06AC03 | Chloropyramine | Solution for Injection | 20 mg/2 ml

R06AX13 | Loratadine | Tablet | 10 mg

S01BA01 | Dexamethasone | Eye drops, solution/drops For the Eye, Suspension | 1mg/1ml

Buyer

PHI University Clinic of Hematology Skopje

Documents

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Information on this page originates from the following sources: TED

Buyer

PHI University Clinic of Hematology Skopje

Deadline passed

Important dates

29 Apr - Publication date

26 May - Deadline

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?

Drugs - 3

Documents

Your privacy is important to us